← FDA Drug Approvals (Drugs@FDA)

RISPERIDONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2023-12-05

Drug application

FDA Application #

ANDA214068

Application type

Abbreviated New Drug Application (Generic)

Brand name

RISPERIDONE

Generic name

RISPERIDONE

Active ingredients

RISPERIDONE

Dosage form

POWDER

Route

INTRAMUSCULAR

Marketing status

Prescription

Sponsor

TEVA PHARMS USA INC

Manufacturer

Teva Pharmaceuticals, Inc.

First approval

2023-12-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown